Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | divalent metal transporter DMT1B | 0.0543 | 1 | 1 |
Mycobacterium tuberculosis | Divalent cation-transport integral membrane protein MntH (BRAMP) (MRAMP) | 0.0335 | 0.5748 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0436 | 0.0436 |
Plasmodium falciparum | transporter, putative | 0.0543 | 1 | 0.5 |
Toxoplasma gondii | divalent metal transporter, putative | 0.0543 | 1 | 0.5 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0436 | 0.0436 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0436 | 0.0436 |
Onchocerca volvulus | Protein Malvolio homolog | 0.0543 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0436 | 0.0436 |
Mycobacterium ulcerans | divalent cation-transport integral membrane protein | 0.0207 | 0.3118 | 0.0542 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0436 | 0.0436 |
Echinococcus granulosus | divalent metal transporter DMT1B | 0.0543 | 1 | 1 |
Mycobacterium ulcerans | divalent cation-transport integral membrane protein | 0.0207 | 0.3118 | 0.0542 |
Schistosoma mansoni | divalent metal transporter DMT1B | 0.0543 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0436 | 0.0436 |
Mycobacterium leprae | possible membrane transport protein | 0.0207 | 0.3118 | 0.1305 |
Loa Loa (eye worm) | hypothetical protein | 0.0543 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0436 | 0.0436 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0436 | 0.0436 |
Schistosoma mansoni | divalent metal transporter DMT1B | 0.0543 | 1 | 1 |
Plasmodium vivax | metal transporter, putative | 0.0543 | 1 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0436 | 0.0436 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0436 | 0.0436 |
Loa Loa (eye worm) | hypothetical protein | 0.0543 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0436 | 0.0436 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0436 | 0.0436 |
Mycobacterium leprae | DIVALENT CATION-TRANSPORT INTEGRAL MEMBRANE PROTEIN MNTH (BRAMP) (MRAMP) | 0.0335 | 0.5748 | 1 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0436 | 0.0436 |
Mycobacterium ulcerans | manganese transport protein MntH | 0.0543 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.6964 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.